Australian mobile health startup iSonea has announced it has raised $1.05 million in a private placement of shares to Investment Holdings Pyt, Ltd, a company owned and operated by prominent Australian businessman Bruce Mathieson.
According to the American Lung Association, more than 7 million children suffer from asthma and it is the leading cause of student absenteeism in the US school system, accounting for 14 million lost school days annually.
iSonea’s product portfolio directly addresses this market and offers a comprehensive asthma management solution.
“iSonea is committed to developing innovative, non-invasive devices and mobile health applications to improve the management of chronic and costly respiratory disorders such as asthma and COPD,” said iSonea CEO Michael Thomas. ”
After the successful launch of our AsthmaSense mobile smartphone app this summer, the company is now focused on integrating our existing proprietary ARM sensors and analytical software with the AsthmaSense mobile smartphone app to develop an app based wheeze monitor known as AirSonea.”
AirSonea will run on iPhone and Android smartphones, enabling anyone, anywhere, at anytime to conveniently monitor asthma events and take appropriate action to control the condition. The app will ultimately replace the company’s Wheezometer (pictured below) as they move away from developing their own proprietary hardware and focus on smart algorithms for smartphones. The company has decided to make their app available for free for the entire month of September to encourage people to use the AsthmaSense system to manage their asthma during the rough fall season.
“Autumn is a tough time for asthmatics, especially children. By offering AsthmaSense free through September, we are increasing access to the most intelligent, easy-to-use asthma management app on the market during this troublesome season,” said Thomas. “At iSonea, we are committed to helping asthmatics breathe easier and we are continuing to develop tools to help people control this disease.”
Another product under development at iSonea is AsthmaSense Cloud, which will allow for data sharing and enhanced capabilities for detecting asthma risk based on changes in environment conditions such as air quality and weather.
Bruce Mathieson is a very well respected Australian business man with an extensive background in starting and managing businesses in the leisure and hospitality industries.
“iSonea is strongly positioned in the new area of digital health,” commented Mathieson. “The asthma monitoring device they are developing to operate with smart phones has enormous potential to help asthmatics worldwide and generate impressive recurring revenue. As the late Steve Jobs said in 2010, ‘one of the biggest innovations of the 21st Century will be the intersection of biology and technology. A new era is beginning, just like the digital one when I was my son’s age.’ I believe iSonea’s products are ahead of the curve and representative of the future of health management.”